Albany, NY, July 31, 2015 (GLOBE NEWSWIRE) -- According to a new market report published by Transparency Market Research "Cardiopulmonary Stress Testing Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023", the global cardiopulmonary stress testing systems market was valued at USD 3,307.5 million in 2014 and is anticipated to expand at a CAGR of 8.2% from 2015 to 2023 to reach USD 6,673.0 million in 2023.
Browse Market Research Report on Cardiopulmonary Stress Testing Systems Market: http://www.transparencymarketresearch.com/cardiopulmonary-stress-testing-systems.html
The global cardiopulmonary stress testing systems (CPST) market is primarily driven by the increasing geriatric population and rising prevalence of coronary artery diseases such as acute myocardial infarction and angina pectoris. The primary goal of cardiac stress testing is to identify the risk stratification of coronary artery disease (CAD), which is one of the most common causes of deaths globally. According to the Centers for Disease Control and Prevention (CDC), coronary heart disease accounts for 370,000 deaths in the U.S. each year. Rising prevalence of lifestyle habits such as smoking, rising incidence of obesity, and dietary irregularities are responsible for the growth of cardiac artery disease globally. The global cardiopulmonary stress testing systems market is also being driven by the introduction of new technologies and eradication of complications associated with stress testing due to the development of robust and flexible devices. The progression from electrocardiographically-based stress testing to SPECT technologies has led to significant improvements in diagnostic resolution and efficacy. SPECT MPI stress tests provide substantially greater information than exercise stress tests in terms of resolution of regional ischemia, assessment of regional wall motion abnormalities, and myocardial viability.
Browse Press Release of Cardiopulmonary Stress Testing Systems Market: http://www.transparencymarketresearch.com/pressrelease/cardiopulmonary-stress-testing-systems.htm
Based on product type, the global cardiopulmonary stress testing market has been categorized into cardiopulmonary exercise testing (CPET) systems, stress ECG, pulse oximeters, stress blood pressure monitors, and single-photon emission computed tomography (SPECT). In terms of revenue, the CPET systems segment accounted for the largest share of the global cardiopulmonary stress testing systems market in 2014. Technological advancements in CPET equipment have enabled physicians to assess the integrative exercise responses involving the cardiovascular, pulmonary, hematopoietic, skeletal muscle systems, and neuropsychological systems that does not reflect adequately through the measurement of individual organ system functions. CPET permits the evaluation of both submaximal and peak exercise responses, thereby assisting doctors with relevant information for clinical decision making. CPET systems have been categorized into two sub-segments: portable CPET systems and stationary CPET systems. Desktop CPET systems dominated the CPET devices market with more than 75% share in 2014. Factors such as small size, light weight, and seamless connectivity with different medical imaging systems are responsible for the dominance of the segment.
Get Sample Report Copy of Cardiopulmonary Stress Testing Systems Market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1530
Philips Healthcare, GE Healthcare, CareFusion Corporation, Spacelabs Healthcare, COSMED, MGC Diagnostic Corporation, Nihon Kohden Corporation, Schiller AG, SunTech Medical, Inc., and Welch Allyn are the major players operating in the global cardiopulmonary stress testing systems market.
Other Reports by Transparency Market Research:
- Compression Therapy Market: http://www.transparencymarketresearch.com/compression-therapy-market.html
- Chromatography Accessories and Consumables Market: http://www.transparencymarketresearch.com/chromatography-accessories-consumables-market.html
- Acid Citrate Dextrose (ACD) Tubes Market: http://www.transparencymarketresearch.com/acid-citrate-dextrose-tubes-market.html
The global cardiopulmonary stress testing systems market is segmented as follows:
Global Cardiopulmonary Stress Testing Systems Market, by Product Type
- Cardiopulmonary Exercise Testing (CPET) Systems
- Portable CPET Systems
- Desktop CPET Systems
- Stress ECG
- Pulse Oximeters
- Stress Blood Pressure Monitors
- SPECT
Global Cardiopulmonary Stress Testing Systems Market, by Geography
North America
- U.S.
- Canada
Europe
- Germany
- U.K.
Rest of Europe
- Asia-Pacific
- China
- India
Rest of Asia Pacific
Latin America (LATAM)
- Brazil
- Mexico
- Rest of LATAM
Middle East and North Africa
- Saudi Arabia
- UAE
- Rest of MENA
Rest of the World (RoW)
Browse All Other Medical Devices Market Research Reports: http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
About Us:
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.